Canaccord Genuity

Aurora Cannabis is a medical marijuana producer.Aurora is committed to providing all of its patients with the highest standard of product quality, customer service, and affordable pricing.

Golden Leaf Holdings is a fast growing company and leading cannabis oil solutions company built around recognized brands. Golden Leaf Holdings is one of the largest cannabis oil and solution providers in North America and is a leading cannabis company in Oregon. With a product portfolio built around recognized brands, the Company strives to provide cannabis users with superior value and experience. We leverage a strong management team and advanced research techniques that complement our expertise in extracting, refining, marketing, and selling cannabis oil. Firmly committed to operational transparency and tight controls, Golden Leaf Holdings demonstrates its resolve to be an industry leader and a partner to communities and regulators

Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Avicanna Inc. is a biopharmaceutical company based in Toronto, Canada, specializing in the research, development, and commercialization of plant-derived cannabinoid-based products for the medical, consumer health, and pharmaceutical sectors. The company offers a range of pharmaceutical-grade cannabinoids, including THC, CBD, and CBG, along with active pharmaceutical ingredients, feminized seeds, and bulk formulations, primarily under the Aureus Santa Marta brand. Avicanna also develops CBD-based derma-cosmetic products for beauty and specialized care under the Pura Earth brand and provides medical cannabis products targeting various health issues, including skin disorders and neurological conditions. Furthermore, the company engages in research collaborations to explore cannabinoid applications, such as developing treatments for COVID-19 induced lung inflammation. Founded in 2016, Avicanna emphasizes an evidence-based approach and maintains vertical integration within the biotechnology and medical cannabis industries.

AYR Wellness aims higher for the wellness of our customers, through the power of cannabis. We grow and sell the highest-quality cannabis products available anywhere, inspiring wellness and wonder in our customers, wherever they are on their cannabis journey. We operate with a sense of responsibility to our customers and patients, building stronger and more socially responsible communities everywhere we go.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Cardiol Therapeutics Inc. focuses on the production of pharmaceutical cannabidiol (CBD) products. The company is also developing various therapies for heart diseases, including acute myocarditis and other causes of heart failure. Its lead product is CardiolRx, a pharmaceutically-produced CBD formulation. In addition, it is developing nanotechnology to deliver pharmaceutical CBD and other anti-inflammatory drugs directly to sites of inflammation in the heart that are associated with heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is based in Oakville, Canada.

Harvest Health and Recreation Inc. (CSE:HARV), is a consistently profitable, vertically integrated cannabis company with one of the largest footprints in the world. Harvest’s industry-leading cultivation, manufacturing, retail facilities, construction, real estate and technologies are backed by experienced, in-house finance, compliance, operations, real estate, human resources, marketing and legal teams, who have a proven and trusted track record in the cannabis industry.

Brains Bioceutical Corp. engages in the production of naturally-sourced active pharmaceutical ingredients (API) for the pharmaceutical and nutraceutical industries. The company offers CBD oil, capsules, balm, and spray. It serves pharmaceutical; health and wellness; skin and beauty; and veterinary sectors. The company is based in Vancouver, Canada.

POSaBIT Systems Corporation is a financial technology company based in Kirkland, Washington, specializing in blockchain-enabled payment processing and point-of-sale systems. The company primarily serves cash-only businesses, with a significant focus on the cannabis industry in the United States. By providing innovative payment solutions, POSaBIT aims to facilitate transactions for merchants operating in a sector that often faces banking challenges.

Aleafia Health is a vertically integrated cannabis company that produces standardized, pesticide-free cannabis for patients in need. The company brings Canadians medical cannabis care through nationwide clinics, world-class cultivation and distribution facilities, and innovative research. It helps ensure physicians make recommendations that have been proven effective through historical data, helping to avoid treatments based on trial and error. Aleafia improves lives by consistently delivering and innovating cannabis health and wellness products and services. They assisting patients who qualify under Health Canada’s Access to Cannabis for Medical Purposes Regulations. The company owns two cannabis cultivation facilities, one of which is licensed and fully operational and one which will be fully operational in late 2018.

Cansortium utilizes a unique combination of capital and expertise in making strategic investments to help launch mature and professional cannabis markets. As global regulations evolve, Consortium Holdings is well-positioned to expand its presence in the U.S. and Puerto Rico. The company was founded in 2016.

The Tinley Beverage Company Inc. manufactures and sells liquor-inspired, non-alcoholic, and cannabis-infused beverages in the United States. It also offers Tinley Tonic and Tinley 27 line of products through retail locations in California; and online in the United States. The company was formerly known as Quia Resources Inc. and changed its name to The Tinley Beverage Company Inc. in October 2015. The Tinley Beverage Company Inc. was incorporated in 2007 and is based in Toronto, Canada.

Origin House is a private equity firm and cannabis product company based in Ottawa, Canada, specializing in the legal cannabis sector. Established in 2015, the firm focuses on acquiring companies with a strategic emphasis on research, intellectual property, consumer brands, and industry infrastructure. Origin House operates primarily in the United States and Canada, seeking to take majority stakes in its investments. In California, it has developed a significant presence by delivering over 130 branded cannabis products to licensed dispensaries, positioning itself as a key player in branding and promoting cannabis products within the largest regulated cannabis market. The company's objective is to become a leading global house of cannabis brands, leveraging its expertise and resources to enhance its market influence.